2013 EACPT Congress Symposia - Neuro-Psychopharmacology: filling the gaps

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on Neuro-Psychopharmacology: filling the gaps
The exact neurobiological mechanisms involved in the therapeutic action of antidepressant are not clearly understood and better knowledge may help to identify new therapeutic targets and to overcome limitations of current treatment, such as poor efficacy and slow onset of action.

Moreover most current psychotropic drugs may be considered as “dirty drugs” as they bind to many different molecular targets in the body, and therefore tend to have a wide range both of therapeutic effects and adverse effects. 
This session will discuss the neurobiology of depression as well as prediction of pharmacological effects of CNS-active agents in humans so as to fill the gap between basic science and potential clinical effectiveness. 
Oral short communications will be selected: abstracts are most welcome!

2013 EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org